Ibuprofen
Pricing Report NDC 68016-030-16

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Ibuprofen Pain Reliever/ Fever Reducer (NDC 68016-030-16) is $0.02763 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 19, 2014.

As a provided by Chain Drug Consortium, this medication is distributed in a 100 TABLET in 1 CARTON configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.02763
Per EA

Effective Date
Nov 19, 2014
Billable Units
100 EA
Estimated Package Price
$2.76
Data Status
As of Nov 19, 2014
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET in 1 CARTON
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.02692 to $0.02839 per EA. Over this 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0269 - $0.0284
Market Volatility
5.46% Variance
Latest Trend
0.83%
Date Unit Price Unit Source Method Rate
Nov 19, 2014 $0.02763 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $0.02763 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2014 $0.02786 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2014 $0.02786 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2014 $0.02794 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2014 $0.02794 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $0.02839 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $0.02839 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $0.02830 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $0.02830 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2014 $0.02728 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2014 $0.02728 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $0.02791 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $0.02791 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2014 $0.02795 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2014 $0.02795 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $0.02692 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $0.02692 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $0.02792 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $0.02792 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026